Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

5Post doubled the number of orders

6/14/24 X5

Rosbank wants to sell mortgage portfolio ahead of T-Bank deal

6/14/24 T

Rosbank wants to sell mortgage portfolio ahead of T-Bank deal

6/14/24 ROSB

Yandex will create a separate brand for unmanned cars and delivery robots

6/14/24 YDEX

Shareholders of IMCB approved dividends for 2023

6/14/24 GEMA

Magnit will build a new logistics complex in the Leningrad Region

6/13/24 MGNT

Yandex closed a deal to purchase the eLama service

6/13/24 YDEX

Bystrinsky GOK to increase ore processing to 20 mln tons by 2030

6/13/24 GMKN

Design of Rusal's alumina refinery will begin in late 2024-early 2025

6/13/24 RUAL

Pyatyorochka is testing delivery from franchise stores

6/13/24 X5